New heart imaging device tested in small study

NCT ID NCT05931835

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new imaging system called VERAFEYE in 18 people already scheduled for standard heart procedures like ablation or closure. Doctors used the device during the procedure and gave feedback via a questionnaire. The goal was to gather information to improve the system, not to prove it works or is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

VERAFEYE System (imaging device)

What this could lead to

If successful, this could help refine a new imaging tool to assist doctors during heart procedures.

What could go wrong

This is a very early feasibility study with only 18 people, not designed to prove safety or effectiveness. Results may not lead to a usable product.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter atrial septal defect

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mater Private Network

    Dublin, Leinster, D07 RD8P, Ireland